Although IL1R2‐neutralizing antibody significantly inhibited cancer cell growth, invasion and chemoresistance in vitro, the application of neutralizing antibody in vivo showed a relatively mild inhibitory effect on tumor growth and chemoresistance to docetaxel in an immunodeficient mouse model. The gene discussed is IL1R2; the disease is neoplasm.